Sanara MedTech (SMTI) Cash from Operations (2010 - 2026)

Sanara MedTech's Cash from Operations history runs 16 years deep, the most recent figure standing at 2465407.0 for Q1 2026.

• Quarterly Cash from Operations fell 23.34% year-over-year to 2465407.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6320106.0 (up 1575.63% YoY) and the FY2025 annual result came in at 6786629.0, up 28634.43% from the prior year.
• Cash from Operations was 2465407.0 for Q1 2026 at Sanara MedTech, down from 3945061.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 3945061.0 in Q4 2025 and bottomed at 2465407.0 in Q1 2026.
• A 5-year average of 264881.65 and a median of 1154317.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations tumbled 245.3% — and 2025, when it soared 323.27%.
• Sanara MedTech's Cash from Operations stood at 645016.0 in 2022, then slumped by 31.55% to 848532.0 in 2023, then jumped by 209.84% to 932047.0 in 2024, then surged by 323.27% to 3945061.0 in 2025, then sank by 162.49% to 2465407.0 in 2026.
• Business Quant data shows SMTI's Cash from Operations at 2465407.0 in Q1 2026, 3945061.0 in Q4 2025, and 2176441.0 in Q3 2025.